News
KCAS Bio scientists contributed to an industry working group publication addressing the development and validation of quantitative PCR (qPCR) and digital PCR (dPCR) assays used in regulated bioanalysis for cell and gene therapies. The publication has been recognized as a 2026 High Impact Article by the AAPS Journal.
Posters & Papers
This article is recognized as a 2026 High Impact Article by the AAPS Journal. This AAPS working group paper provides industry considerations for the design, development, and validation of qPCR and dPCR assays used in regulated bioanalysis for cell and gene therapies. Developed by 37 experts from 24 organizations,…
Blogs
In today’s fast-moving drug development landscape, bioanalytical continuity and end-to-end support aren’t just conveniences, they’re competitive advantages. Sponsors navigating complex modalities like gene therapies, ADCs, oligonucleotides, and biologics need a partner who can keep pace with aggressive timelines, shifting priorities, and evolving regulatory expectations. Why Continuity Matters in…
March 19
- March 20
KCAS Bio will attending the Boston Society Gene and Cell Therapy Conference, taking place in Cambridge, Massachusetts, on March 19-20, 2026. This event gathers leading experts, innovators, and researchers to explore the latest advancements in gene and cell therapy. Advancing Gene and Cell Therapy with Bioanalytical Expertise Gene…
Blogs
What is Immunogenicity Assessment? Immunogenicity refers to the ability of a substance, such as a New Biological Entity (NBE) or a vaccine, to provoke an immune response when administered in the body. The recognition of the substance as foreign triggers an immune response, which involves the production of antibodies and…
Podcasts
In Episode 88 of The Weekly Bioanalysis, hosts Dominic Warrino, Ph.D. and John Perkins, Ph.D present a special WRIB 2025 recap featuring several KCAS Bio scientists who share firsthand insights from their presentations at the major bioanalytical conference. David Ambrose highlights KCAS Bio’s global harmonization of spectral flow cytometry instruments…
Blogs
Initially developed to assess the frequency of circulating antigen-specific Antibody-Secreting Cells (ASC), ELISpot has become a vital tool for quantifying antigen-reactive T-cells by measuring secreted immune mediators such as cytokines or key molecules involved in cell-mediated cytotoxicity. Compared to other assays for monitoring cell-mediated immunity (CMI), such as…
Podcasts
In this engaging episode of the podcast, hosts Brian Wile and Adam Cotty welcome special guests Michael Naso, Hillary Quinn, and Barry Morse from The Therapeutic Innovations Group—a powerhouse team of scientists and biotech veterans with decades of experience across biologics, small molecules, and cell therapy. The conversation dives…
Blogs
When you examine how to develop and validate/qualify a Biodistribution assay by PCR…
Blogs
Cell and Gene Therapies (CGTs) are types of treatment that uses cellular or genetic material with the goal of treating a disease or a disordered. Often it can be a combination of cell and gene therapies, which is the case for Chimeric antigen receptor T cells (CAR T-Cells). There are…
Posters & Papers
Please download this poster, “Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis”
April 9
- April 11
The Cell & Gene Meeting on the Med is a premier European conference focusing on advanced therapy medicinal products (ATMPs). ATMPs are a revolutionary class of treatments that involve modifying a patient’s cells to fight disease. This conference unites researchers, developers, manufacturers, and other stakeholders from around the world…